References
U.S. Leprosy Panel (U.S.-Japan Cooperative Medical Science Program). Leonard Wood Memorial Spaced clofazimine therapy of lepromatous leprosy. Am J Trop Med Hyg. 1976;25:437–44.
Barry VC, Buggle K, Byrne J, Conalty ML, Winder F. Absorption, distribution and retention of the rimino compounds in the experimental animal. Ir J Med Sci. 1960;416:345–52.
Geboes K, Hertogh GD, Ectors N. Drug-induced pathology in the large intestine. Curr Diagn Pathol. 2006;12:239–47.
Szeto W, Garcia-Buitrago MT, Abbo L, Rosenblatt JD, Moshiree B, Morris MI. Clofazimine enteropathy: a rare and underrecognized complication of mycobacterial therapy. Open Forum Infect Dis. 2016;3:ofw004.
Baik J, Stringer KA, Mane G, Rosania GR. Multiscale distribution and bioaccumulation analysis of clofazimine reveals a massive immune system-mediated xenobiotic sequestration response. Antimicrob Agents Chemother. 2013;57:1218–30.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
NPB, PA, AJ, and DD declare that they have no conflict of interest.
Disclaimer
The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology or the printer/publishers are responsible for the results/findings and content of this article.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bhangale, N.P., Abraham, P., Joshi, A. et al. Clofazimine-related duodenal pigmentation. Indian J Gastroenterol 40, 347–348 (2021). https://doi.org/10.1007/s12664-020-01128-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12664-020-01128-6